Catalog Products » Catalog Peptide » SARS-CoV-2 Spike Glycoprotein B.1.1.7-Alpha
Manual
COAs
HPLC
MS

SARS-CoV-2 Spike Glycoprotein B.1.1.7-Alpha

This pool is delivered in two subpools of 158 & 157 peptides derived from a peptide scan (15mers with 11 aa overlap) through the entire Spike glycoprotein of SARS-CoV-2 B.1.1.7, UK (Severe Acute Respiratory Syndrome-related coronavirus 2, Lineage B.1.1.7), covering the following mutations: HV 69-70 deletion, Y144 deletion, N501Y, A570D, P681H, T716I, S982A, D1118H and additional mutation D614G.
$716.00
RP30025

Ask us a question
Overview
Description This pool is delivered in two subpools of 158 & 157 peptides derived from a peptide scan (15mers with 11 aa overlap) through the entire Spike glycoprotein of SARS-CoV-2 B.1.1.7, UK (Severe Acute Respiratory Syndrome-related coronavirus 2, Lineage B.1.1.7), covering the following mutations: HV 69-70 deletion, Y144 deletion, N501Y, A570D, P681H, T716I, S982A, D1118H and additional mutation D614G. 
Back

Properties
Source Severe Acute Respiratory Syndrome-related coronavirus 2 (Lineage B.1.1.7) Spike glycoprotein (covering the following mutations: HV 69-70 deletion, Y144 deletion, N501Y, A570D, P681H, T716I, S982A, D1118H and additional mutation D614G).
Gene ID S
Length 1270 aa
Purity Crude (Major peak by ESI-MS is guaranteed to be peptide of interest - determined at 220 nm for each individual peptide).
Solubility Dissolve in a minimum amount of pure DMSO (approx. 40 µl) and dilute with PBS buffer to the final concentration. Please note that the final concentration of DMSO must be below 1 % (v/v) to avoid toxicity in the biological system.
Form Lyophilized
Storage Store at -20°C.
Note The peptides of this product are supplied as trifluoroacetate salts.
Back

Please note that we do not provide HPLC and MS reports for each individual peptide within our peptide library products.